UMB Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Buy
54,146
+339
+0.6% +$14.6K 0.03% 244
2026
Q1
$1.98M Sell
53,807
-1,745
-3% -$82.7K 0.03% 272
2025
Q4
$2.83M Buy
55,552
+8,722
+19% +$446K 0.04% 234
2025
Q3
$2.6M Buy
46,830
+6,241
+15% +$365K 0.04% 227
2025
Q2
$2.8M Sell
40,589
-231
-0.6% -$15.7K 0.04% 215
2025
Q1
$2.83M Sell
40,820
-610
-1% -$50.4K 0.05% 207
2024
Q4
$3.56M Sell
41,430
-334
-0.8% -$36.1K 0.06% 188
2024
Q3
$4.97M Sell
41,764
-448
-1% -$59.7K 0.08% 155
2024
Q2
$6.03M Sell
42,212
-3,030
-7% -$402K 0.1% 142
2024
Q1
$5.81M Sell
45,242
-1,279
-3% -$152K 0.09% 152
2023
Q4
$4.81M Sell
46,521
-1,323
-3% -$131K 0.07% 166
2023
Q3
$4.35M Sell
47,844
-94
-0.2% -$8.28K 0.07% 176
2023
Q2
$3.88M Buy
47,938
+448
+0.9% +$36.6K 0.06% 189
2023
Q1
$3.78M Buy
47,490
+720
+2% +$51.1K 0.06% 192
2022
Q4
$3.17M Sell
46,770
-820
-2% -$48.1K 0.05% 210
2022
Q3
$2.37M Sell
47,590
-1,342
-3% -$71.9K 0.04% 239
2022
Q2
$2.73M Sell
48,932
-920
-2% -$51.1K 0.04% 245
2022
Q1
$2.77M Sell
49,852
-80
-0.2% -$4.11K 0.04% 258
2021
Q4
$2.8M Buy
+49,932
New +$2.71M 0.04% 258

Other funds holding NVO

UMB Bank's NVO Position: Q2 2026 in Review

UMB Bank increased its Novo Nordisk (NVO) stake by 0.63% in Q2 2026, buying an estimated $14.6K and bringing the position to 54,146 shares worth $2.6M. The position accounts for 0.03% of the portfolio, ranked #244.

UMB Bank first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.03M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • UMB Bank held 54,146 shares of Novo Nordisk worth $2.6M as of Q2 2026.
  • UMB Bank bought 339 Novo Nordisk shares in Q2 2026, an estimated $14.6K.
  • Novo Nordisk made up 0.03% of UMB Bank's portfolio in Q2 2026, its #244 holding.
  • UMB Bank first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Novo Nordisk position peaked at $6.03M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.